Full-Time

Speech Language Pathologist

Speech-Language Pathology

Tufts Medicine

Tufts Medicine

501-1,000 employees

Integrated health system delivering connected care

Compensation Overview

$84.3k - $107.5k/yr

Malden, MA, USA

In Person

Position covers Malden and surrounding areas.

Master's

Category
Medical, Clinical & Veterinary (1)
Required Skills
Basic Life Support (BLS)

Get referred to Tufts Medicine

See people who can refer or advise you

Requirements
  • A Master’s degree in Speech-Language Pathology is required.
  • A Certificate of Clinical Competence from the American Speech and Hearing Association is required.
  • A Speech Therapist license is required.
  • Basic Life Support certification is required.
  • Five years of experience in Speech-Language Pathology is required.
  • The clinician must have broad knowledge and skills in diagnosing and treating speech, language, cognitive, communicative, and swallowing disorders.
  • The clinician must be able to read, write, and communicate in English.
  • The clinician must be able to assess patients across all age populations and provide appropriate care.
  • The clinician must be able to observe treatment effects and adjust the plan of care appropriately.
  • The clinician must demonstrate time-management skills to meet department productivity requirements while maintaining quality patient care.
  • The role requires frequent standing, walking, and transferring of patients.
  • The role requires manual dexterity for computer keyboard use, quantitative testing, and manual treatment techniques.
  • The role requires the ability to see computer screens and reports and visually assess injuries and functional status, as well as audibly assess patient complaints.
Responsibilities
  • Evaluate and screen complex patients referred to Speech and Language Pathology across ages from infancy to adulthood.
  • Evaluate patient status using behavioral observations, case histories, and standardized test results, and make diagnoses using accepted professional standards.
  • Recommend therapy, further consultations, extended speech and language evaluations, or home training programs.
  • Prepare complete written evaluation and progress reports.
  • Consult with patients, clients, and caregivers about recommendations and carryover programs, and evaluate the effectiveness of home programs.
  • Determine realistic goals and dismissal criteria, and identify supplemental materials to improve patient and family understanding of speech, language, and swallowing disorders.
  • Select and provide appropriate tests, measures, and rehabilitation services.
  • Inform and consult with medical personnel about the type, extent, and prognosis of speech and language disorders in relation to medical procedures.
  • Provide individual client follow-up, communicate with other professional disciplines and social service agencies, and participate in interdisciplinary and family conferences to coordinate services.
  • Complete evaluation reports, progress notes, reassessments, and discharge summaries, and comply with insurance requirements including obtaining physician signatures and approvals.
  • Coordinate the Graduate Student Internship program in Speech-Language Pathology, including contacting graduate programs, developing criteria and clinical procedures, setting caseload sizes, and evaluating interns’ clinical skills.
  • Schedule and provide in-service training to professionals, groups, and service providers about speech, language, and swallowing disorders in infants and children.
  • Coordinate and oversee day-to-day Speech and Language Program operations, including scheduling, hiring, and training.
  • Conduct annual performance evaluations of Speech Therapy staff.
  • Monitor workloads and assist with scheduling sufficient clinical activity to meet workload requirements.
  • Keep current with professional literature and acquire knowledge of new tests, instruments, and equipment.
  • Maintain working knowledge of patient care programs and devices available to patients.
  • Initiate or participate in research projects as required.
  • Perform related bookkeeping duties.
Desired Qualifications
  • Six years of experience, including two years of experience with patients who have head injuries.
  • Training and experience as a Pediatric Dysphagia Specialist.

Tufts Medicine is an integrated health system in Massachusetts that combines academic medical centers, community hospitals, a large home care network, and a clinically integrated physician network to deliver coordinated care. It includes Tufts Medical Center, Lowell General, MelroseWakefield, home health services, and a broad physician network, enabling care across settings. The system coordinates hospitals, doctors, and home care under one strategy to manage the patient journey, reduce fragmentation, and control costs while maintaining quality. Its goal is to deliver high-quality care at the lowest possible cost, expand access, and transform how people engage with healthcare.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Burlington, Massachusetts

Founded

2014

Get referred to Tufts Medicine

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • John Herman became Tufts Medical Center president in September 2025, adding turnaround experience.
  • May 2026 Vardas hire signals cardiovascular growth, innovation, and multidisciplinary referrals.
  • NENA's 2024 merger brought 75 neuroscience clinicians into Tufts Medicine's network.

What critics are saying

  • August 6, 2026, CEO Mike Dandorph and CFO Andrew DeVoe exit during turnaround.
  • 2024 layoffs of 174 staff and 2023 cuts show persistent cost pressure.
  • April 2026 faculty verdict exposed governance weakness; appeals losses compound liquidity strain.

What makes Tufts Medicine unique

  • Tufts Medicine spans an academic center, community hospitals, care-at-home, and 2,300 physicians.
  • May 7, 2026, Panos Vardas deepens complex valve and structural heart surgery capability.
  • Navvis gives Tufts Medicine value-based care operations across Massachusetts and southern New Hampshire.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Company Match

403(b) Retirement Plan

Tuition Reimbursement

Company News

Tufts Medicine
May 7th, 2026
Header utility.

Header utility. May 7, 2026 Distinguished cardiac surgeon brings national leadership in complex valve and structural heart surgery to advance growth, innovation and multidisciplinary cardiovascular care across Tufts Medicine Tufts Medicine announced today that Dr. Panayotis (Panos) Vardas, has been named Division Chief of Cardiac Surgery at Tufts Medical Center (Tufts MC), with an academic appointment at Tufts University School of Medicine. Dr. Vardas, an internationally recognized cardiac surgeon, will advance the clinical, academic and research mission of the Division of Cardiac Surgery and contribute to the growth of cardiovascular services across Tufts Medicine. Dr. Vardas will also promote patient-centered, multidisciplinary, collaborative, high-quality cardiac surgical care and ensure equitable access to advanced cardiothoracic surgical services across Tufts Medicine. "Dr. Vardas joins us at an exciting time for cardiovascular services at Tufts Medical Center and across Tufts Medicine," said Erika Werner, MD, Chief Physician Executive of Tufts Medicine, President of the Tufts Medical Center Physicians Organization, and a Professor at Tufts University School of Medicine. "His proven track record in advancing surgical excellence and building high-performing programs, combined with his dedication to education and research, will be instrumental in strengthening our cardiac surgery program and expanding access to innovative cardiac care for the communities we serve." Dr. Vardas practices the full spectrum of adult cardiac surgery with a specialized clinical focus on complex valve disease and structural heart interventions. His clinical expertise emphasizes durable valve repair, percutaneous and transcatheter valve interventions, arrhythmia surgery, surgical coronary revascularization and complex reoperative cardiac surgery. In addition to his clinical leadership, Dr. Vardas brings a strong academic profile and a commitment to innovation. He has been actively involved in clinical trials, outcomes research and guideline development, with a focus on valve disease, arrhythmia surgery and advanced surgical and transcatheter technologies. His scholarly work has been published in leading peer-reviewed journals, and he has served in leadership roles within several professional societies, including the Society of Thoracic Surgeons, American Association for Thoracic Surgery, Eastern Cardiothoracic Surgical Society and the Thoracic Surgery Directors Association. Dr. Vardas joins Tufts MC from the University of Alabama at Birmingham (UAB), where he served as a Tenured Associate Professor in the Division of Cardiothoracic Surgery, Medical Director of the Cardiac Surgery Intensive Care Units and Associate Program Director of the Cardiothoracic Surgery Residency and Fellowship. He has received multiple national honors, including the Society of Thoracic Surgeons President's Award, and was recently inducted into the American Association for Thoracic Surgery, one of the most prestigious professional societies in the field, in recognition of his contributions to cardiothoracic surgical education and research. "Tufts Medical Center and Tufts University School of Medicine are nationally renowned for excellence in cardiovascular care and a unique opportunity for growth," said Dr. Vardas. "I'm honored to join this outstanding team and look forward to working collaboratively to build a leading cardiac surgery program focused on innovation, multidisciplinary care and exceptional patient outcomes. Dr. Vardas earned his Medical Degree from the University of Rome "La Sapienza" School of Medicine. He completed general surgery training at the University of Washington, followed by an integrated thoracic surgery residency at Indiana University School of Medicine, and an advanced fellowship in complex valve reconstructive and arrhythmia surgery at Northwestern University. He is certified by the American Board of Thoracic Surgery.

Aalborg University
Dec 10th, 2025
Persistent inequity in survival after atrial fibrillation

Persistent inequity in survival after atrial fibrillation. Atrial fibrillation, also known as AF or Afib, is one of the most common cardiovascular diseases. In fact, one in three individuals can expect to be diagnosed by the condition, which increases the risk of serious complications such as heart failure and stroke. Despite significant advances in the treatment of atrial fibrillation, a new Danish study from Aalborg University shows that social inequities in survival have remained virtually unchanged over the past 20 years. The article has just been published in the internationally recognized journal The Lancet Public Health in collaboration with the University of Liverpool, Tufts Medical Center in Boston, and Boston University. The study is based on nationwide Danish registry data from more than 380,000 patients diagnosed with atrial fibrillation between 2000 and 2022 and documents inequities in income, education, and social relationships still have a major impact on life expectancy after diagnosis. Individuals diagnosed with AF who have a low income live on average 2.5 years shorter than those with high income. Low educational level results in a loss of 1.8 years of life, while living alone costs about 1.6 years. "Advances in the management and treatment of atrial fibrillation have improved survival for everyone but have not closed the gap between social groups. This is clearly a problem in a tax-funded universal healthcare system with formally equal access to treatment for all - especially when we know how much prevention can actually matter," says the study's lead author, Nicklas Vinter, MD, PhD, and postdoctoral researcher at the Danish Center for Health Services Research at Aalborg University. He also points out that the global incidence of atrial fibrillation is rising, making the results relevant far beyond Denmark's borders. This is clearly a problem in a tax-funded universal healthcare system with formally equal access to treatment for all - especially when Adsl Aau know how much prevention can actually matter. Social and structural barriers must be addressed. According to Nicklas Vinter, the causes of inequity are not only linked to medical treatment but also to social and behavioral factors. For some patients, treatment guidelines can be difficult to understand and translate into concrete action, and many lack a social network that can provide practical support in everyday life. Therefore, the researchers behind the study propose a new tool, FAIR-PRO-AF, which can help decision-makers and researchers across sectors systematically reduce inequity and create continuous improvements. The tool is designed as a circular work cycle: first, the social factors associated with survival are mapped. Next, the barriers that hinder equity in access, quality, and effectiveness of treatment are identified. In the third step, concrete initiatives are prioritized and implemented, and finally, the effect is evaluated before the cycle moves on to the next round. "The social and structural barriers that limit patients' access to knowledge, resources, and support must be addressed if we want to improve prognoses for all. This requires a broader effort where the healthcare system collaborates with social and political actors," says Nicklas Vinter. Facts: Atrial fibrillation * Atrial fibrillation is the most common cardiac arrhythmia. * Symptoms of atrial fibrillation include shortness of breath, palpitations, and chest pain. * The condition is associated with increased mortality - on average, a patient with atrial fibrillation loses about two years of expected lifespan compared to individuals without the diagnosis. * In Denmark, more than 170,000 people live with the condition, * Each year, more than 20,000 Danes receive the new diagnosis. Read the scientific article: Temporal trends in associations between social drivers and life-years lost in newly diagnosed atrial fibrillation in Denmark, 2000 - 22: a nationwide cohort study Published in The Lancet Public Health, December 2025. Authors: Nicklas Vinter, Søren Paaske Johnsen, Gregory Yoke Hong Lip, Ludovic Trinquart, Lars Frost and Emelia J. Benjamin.

Central Penn Business Journal
Jun 30th, 2025
Former CEO of Penn Medicine LGH named president of Tufts Medical Center

Former Penn Medicine Lancaster General Health Chief Executive Officer John Herman has been appointed as the new President of Tufts Medical Center in Boston, the health system's academic medical center.

The Indian EYE
May 30th, 2025
Dr. Soma Sengupta appointed Tufts University's New Chair of the Department of Neurology

Dr. Soma Sengupta, MD, PhD, MBA, FRCP, FANA, FAAN will join Tufts Medical Center (Tufts MC) as Chair of the Department of Neurology and Neurologist-in-Chief in September 2025.

The Boston Globe
Mar 20th, 2025
Lawrence General, Holy Family hospitals appoint new interim CEO

After a challenging year for Lawrence General Hospital and Holy Family Hospital, former Tufts Medical executive Diana L. Richardson will take over as interim president and CEO next month, the hospital system announced Thursday.